missing translation for 'onlineSavingsMsg'
Learn More

APRIL/TNFSF13 Antibody (670840) [Janelia Fluor™ 669], Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB8843JF669

Product Code. 30171769

  • 5870.00 NOK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

APRIL/TNFSF13 Monoclonal antibody specifically detects APRIL/TNFSF13 in Human samples. It is validated for Flow Cytometry (Intracellular Staining),CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

APRIL/TNFSF13
Monoclonal
Janelia Fluor 669
A proliferation-inducing ligand, APRILFLJ57090, CD256, CD256 antigen, TALL2, TALL-2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TRDL-1, tumor necrosis factor (ligand) superfamily, member 13, tumor necrosis factor ligand superfamily member 13, tumor necrosis factor-like protein ZTNF2, tumor necrosis factor-related death ligand-1, ZTNF2
Human embryonic kidney cell line HEK293EBNA-derived recombinant human APRIL/TNFSF13, Ala105-Leu250, Accession # O75888
RUO
Primary
Human
Liquid
Flow Cytometry (Intracellular Staining), CyTOF
670840
50mM Sodium Borate
Mouse
0.1 mL
Apoptosis, Biologically Active Proteins, Cell Cycle and Replication, Cytokine Research, Immunology
8741
Store at 4°C in the dark.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.